SCAGGIANTE, BRUNA
 Distribuzione geografica
Continente #
EU - Europa 28.970
NA - Nord America 11.445
AS - Asia 5.593
Continente sconosciuto - Info sul continente non disponibili 651
SA - Sud America 588
AF - Africa 128
OC - Oceania 28
Totale 47.403
Nazione #
IT - Italia 22.696
US - Stati Uniti d'America 11.236
SG - Singapore 1.898
CN - Cina 1.382
PL - Polonia 1.369
SE - Svezia 829
FR - Francia 749
UA - Ucraina 567
DE - Germania 563
VN - Vietnam 562
HK - Hong Kong 488
BR - Brasile 457
GB - Regno Unito 416
KR - Corea 383
NL - Olanda 338
FI - Finlandia 308
RU - Federazione Russa 256
TR - Turchia 228
CH - Svizzera 168
BD - Bangladesh 161
IN - India 141
BG - Bulgaria 140
IE - Irlanda 133
CA - Canada 118
ES - Italia 83
BE - Belgio 72
RO - Romania 52
MX - Messico 46
JP - Giappone 45
MA - Marocco 45
IQ - Iraq 37
AR - Argentina 36
IR - Iran 33
AL - Albania 32
AT - Austria 30
SA - Arabia Saudita 28
ZA - Sudafrica 27
EU - Europa 26
AU - Australia 25
EC - Ecuador 24
ID - Indonesia 24
PK - Pakistan 24
PT - Portogallo 22
DK - Danimarca 20
GR - Grecia 17
JO - Giordania 16
SI - Slovenia 16
TH - Thailandia 15
UZ - Uzbekistan 15
CO - Colombia 14
CZ - Repubblica Ceca 13
IL - Israele 12
MY - Malesia 12
PY - Paraguay 12
VE - Venezuela 12
AZ - Azerbaigian 11
CL - Cile 11
EG - Egitto 11
LT - Lituania 11
PE - Perù 11
KE - Kenya 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
RS - Serbia 9
SN - Senegal 9
CR - Costa Rica 8
HU - Ungheria 8
PH - Filippine 8
HR - Croazia 7
JM - Giamaica 7
KZ - Kazakistan 7
NI - Nicaragua 7
NP - Nepal 7
SK - Slovacchia (Repubblica Slovacca) 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
LU - Lussemburgo 6
SM - San Marino 6
BY - Bielorussia 5
EE - Estonia 5
GE - Georgia 5
MD - Moldavia 5
OM - Oman 5
UY - Uruguay 5
BH - Bahrain 4
LB - Libano 4
LV - Lettonia 4
MO - Macao, regione amministrativa speciale della Cina 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
GD - Grenada 3
GT - Guatemala 3
PA - Panama 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CI - Costa d'Avorio 2
GY - Guiana 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
Totale 46.740
Città #
Rome 1.227
Milan 1.224
Warsaw 1.199
Ashburn 1.170
Singapore 1.106
Ann Arbor 1.000
Chandler 721
Trieste 707
Woodbridge 676
San Jose 647
Fairfield 545
Houston 532
Jacksonville 510
Hong Kong 462
Hefei 398
Seoul 372
Naples 352
Wilmington 320
Beijing 306
Council Bluffs 271
Florence 250
Turin 227
Seattle 225
Boardman 223
Bologna 219
Padova 217
Princeton 216
Columbus 206
Izmir 190
Dallas 187
Los Angeles 176
Palermo 175
Cambridge 169
Ho Chi Minh City 165
Chicago 163
Santa Clara 158
Hanoi 142
Napoli 140
Sofia 134
Dublin 127
Bari 126
Lauterbourg 117
Torino 113
Genoa 112
Moscow 112
The Dalles 112
Dearborn 107
Zgierz 107
Brescia 102
Catania 102
Helsinki 98
New York 91
Udine 86
Buffalo 83
Cagliari 82
Verona 81
Venezia 79
London 73
Munich 72
Perugia 68
Frankfurt am Main 67
Bergamo 64
Venice 62
Treviso 59
Amsterdam 57
Brussels 57
Düsseldorf 57
Redwood City 55
Duino-Aurisina 52
São Paulo 50
Caserta 48
Pescara 48
Monza 47
Genova 44
Messina 44
Mountain View 43
Atlanta 42
Toronto 41
Como 40
San Diego 39
Vicenza 39
Reggio Calabria 38
Orem 37
Casablanca 36
Modena 36
Pisa 36
Turku 36
Lucca 35
Redmond 35
Phoenix 34
Falls Church 33
Mestre 32
Sassari 32
Shanghai 32
Ancona 31
North Bergen 31
Salerno 31
Taranto 31
Tokyo 31
Latina 29
Totale 21.068
Nome #
Valutazione quantitativa di Ki-67 nel carcinoma mammario: comparazione tra lettura al microscopio ottico e lettura con analizzatore automatico 21.871
VALUTAZIONE DEL TOUCH-IMPRINT CITOLOGICO NEL TRATTAMENTO DEL CANCRO DELLA MAMMELLA 1.388
Studio pilota sul ruolo dell’allattamento e dei fattori riproduttivi nel rischio dei carcinomi mammari Luminali nelle donne in premenopausa 474
Analisi dei tempi d’attesa tra le varie fasi di gestione dei carcinomi mammari screening-detected a Trieste nel biennio 2013-2014: come si può migliorare? 462
NEODUCTGENESIS AS A PROGNOSTIC MARKER IN “DUCTAL” CARCINOMA IN SITU OF THE BREAST 437
Breastfeeding: a reproductive factor able to reduce the risk of luminal B breast cancer in premenopausal White women 407
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? 404
GT75 aptamer against eukaryotic elongation factor 1A as potential anticancer drug for castrate-resistant prostate cancer (CRPC). 400
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 343
Therapeutic potential of Nucleic acid-based drugs in coronary hyper-proliferative vascular diseases 335
Parità e Allattamento quali fattori protettivi di carcinoma mammario nelle donne triestine 333
Breastfeeding is an additional protective factor for breast cancer among women living in the metropolitan area of Trieste. 332
Therapeutic potential and delivery strategies for nucleic acid-based drugs 311
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 298
The relevance of chemobrain in breast cancer survivors: An Italian exploratory study to measure incidence and psycho-social impact 292
Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis 291
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 287
Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study. 280
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 278
Aptameric GT oligomers need to be complexed to ethoxylated polyethylenimine as pre-paired duplexes to efficiently exert their cytotoxic activity in human lymphoblastic cancer cells 277
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 272
Membranes in Drug Delivery 266
Analisi delle caratteristiche dei carcinomi d’intervallo e screening detected a 10 anni dall’attivazione del programma di screening mammografico regionale del Friuli Venezia-Giulia nella provincia di Trieste 264
Effect of cations on purine.purine.pyrimidine triple helix formation in mixed valence salt solutions. 259
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 258
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 257
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 257
"Human cancer cell lines growth inhibition by GTn oligodeoxyribonucleotides recognizing single stranded DNA-binding proteins" 255
An update of aberrant methylation detection on circulating cell-free DNA as a tool to improve prostate cancer diagnosis and prognosis 254
A rapid and specific method to simultaneously quantify eukaryoticelongation factor 1A1 and A2 protein levels in cancer cells 253
Translation Elongation 252
Caratteristiche dei carcinomi screening-detected a 6 anni dall’ avvio del programma di screening mammografico a Trieste 245
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 243
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 240
PDPG Polymer as a targeted delivery system for siRNAs to hepatocellular carcinoma cells 237
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 225
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 220
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 216
EEF1A1 (eukaryotic translation elongation factor 1 alpha 1) (6q.13) Atlas Genet Cytogenet Oncol Haematol 14 (4):660-670. 216
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 216
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade 211
Ruolo della FNAC nel programma di Screening Mammografico a Trieste 211
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 203
Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patients. 202
Anxiety stress and nociceptive responses in mice. 200
Bortezomib effect of E2F and cyclin family members in human hepatocellular carcinoma cell lines 200
High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1–Actin Complex as a New Potential Target for Therapy 200
Formation of triple helices at irregular RY sites located in the critical position in the human bcr promoter. 195
Epigenetic and miRNAs dysregulation in prostate cancer: the role of nutraceuticals. 194
Diurnal changes of tonic nociceptive responses in mice: evidence for a proalgesic role for melatonin 190
Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules 189
Improving siRNA Bio-Distribution and Minimizing Side Effects 188
Protein phosphorylation and neutrophil activation 187
Evaluation of circulating cell-free DNA and its integrity as a potential predictive biomarker of breast cancer onset: A pilot study 186
Impact of psychosocial, behavioral and lifestyle factors on subjective cognitive complaints and perceived quality of life in a large cohort of Italian breast cancer patients 184
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 181
Nucleic Acids-based Aptamers and their applications 180
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets 179
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer 179
“Alpha-anomeric configuration of GT oligodeoxynucleotide leads to loss of specific aptameric and cytotoxic properties retained by the Beta-anomeric analog” 170
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells 167
“The expression levels of the translational factors eEF1A1/2 correlate with the cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade” 166
A pivotal study in human prostate cancer tissues and cell lines to measure the expression levels of eukaryotic Elongation Factor 1A proteins and the effect of a nucleic acid-based GT75 aptamer 166
An Overview of siRNA Delivery Strategies for Urological Cancers 166
The Role of the eEF1A Family in Human Cancers 165
Two-Dimensional Enzyme Diffusion Demonstrated in Laterally Confined DNA Monolayers 164
Attivazione dell'espressione di elongation factor 1A2 nei tumori prostatici 163
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells 162
"Reduction of mdr1 gene amplification in human multidrug resistant LoVo dX cellline is promoted by triple-helix forming oligonucleotides" 162
Triple-helix forming oligodeoxyribonucleotide, inhibiting mdr1 transcription may reduce mdr1 gene amplification level in multidrug-resistant leukaemic cell line 158
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches 157
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 156
An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer 155
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 155
null 150
“Impianto di cellule epiteliali amniotiche umane crioconservate in un soggetto affetto da malattia di Niemann-Pick tipo B.” 149
Repeated Implantations of human amniotic epithelial cells as a curative therapy of Niemann-Pick disease 149
Medicine, Biology and mathematics 148
Scalp cooling system to prevent alopecia: Effectiveness, psychological effects and feasibility 147
A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection 147
Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell lines. 146
“Effect of phosphorotioate modifications on the GTn oligodeoxynucleotide ability to recognise the single stranded DNA binding proteins specifically related to the human cancer cellular growth inhibition” 141
“The anti-gene DNA strategy by triple helix directed oligodeoxyribonucleotides to modulate human mdr1 gene expression.” 140
Small, antibacterial and large, inactive peptides of neutrophil granules share immunoreactivity to a monoclonal antibody. 138
“Increase of therapeutic index of doxorubicin and vinblastine by aptameric oligonucleotide in human T-lymphoblastic drug-sensitive and multidrug-resistant cells.” 137
Identification of nuclear elongation factor 1 alpha as single-stranded DNA-binding protein specifically recognising GT oligodeoxynucleotides that exert a selective human cancer cell growth inhibition 137
null 136
Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application? 136
Programmi di mindfulness online per pazienti oncologici: quali benefici nei percorsi di cura. Una revisione della letteratura e lo stato dell'arte 135
Potential Application Of Proteasome Inhibitor Bortezomib For Treatment Of Hepatocellular Carcinoma 135
Effect of oligomer length and base substitutions on the cytotoxic activity and specific nuclear protein recognition of GTn oligonucleotides in the human leukemic CCRF-CEM cell line.” 133
“Correlation between cytotoxic effect and binding to nuclear proteins of oligomeric d(GT)n sequences in human cancer CCRF-CEM cell line.” 133
Evaluation of bortezomib impact on cell-cycle related genes in the hepatocellular carcinoma cell lines hepg2 and jhh6 by means of microarray analysis 133
Potential Application Of Proteasome Inhibitor Bortezomib For the Treatment Of Hepatocellular Carcinoma 133
dGT sequences specifically and selectively inhibiting growth of human cancer cell lines, recognise single-stranded DNA-binding proteins 131
New challenges in hepatocellular carcinoma: A role for PIWI-interacting RNAs? 128
Recent advances in optimizing siRNA delivery to hepatocellular carcinoma cells 128
Ethoxylated polyethylenimine successfully enhances the cytotoxic activity of GT oligomers targeted to specific nuclear proteins in human T-Lymphoblastic cancer cells. 127
The more basic isoform of eEF1A relates to tumour cell phenotype and is modulated by hyper-proliferative/differentiating stimuli in normal lymphocytes and CCRF-CEM T-lymphoblasts 126
Triple-stranded DNA: formation, stability and application in biology.” 125
Totale 44.064
Categoria #
all - tutte 95.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.591 0 0 174 304 164 192 150 221 326 271 251 538
2022/20235.954 447 503 469 551 450 647 349 572 561 338 541 526
2023/20244.722 506 446 393 367 413 301 504 547 111 406 392 336
2024/20254.714 324 343 454 397 441 477 298 300 524 409 377 370
2025/20267.522 815 478 604 672 555 693 957 254 884 998 344 268
2026/20271.046 221 435 390 0 0 0 0 0 0 0 0 0
Totale 47.403